Table 3.
Association of ZHX3 and clinical factors with overall survival.
| Unadjusted HR (95% CI) * | P | Unadjusted HR (95% CI) † | P | |
|---|---|---|---|---|
| ZHX3 low expression | 0.406(0.241–0.684) | 0.001 | 0.510(0.298–0.873) | 0.014 |
| Gender | 0.935(0.571–1.531) | 0.788 | - | - |
| Age at diagnosis | 0.974(0.602–1.575) | 0.914 | - | - |
| Tumor site | 0.935(0.575–1.522) | 0.788 | - | - |
| Tumor size | 2.686(1.621–4.450) | <0.001 | 2.169(1.281–3.671) | 0.004 |
| Depth of invasion | 2.458(1.469–4.114) | 0.001 | 2.110(1.253–3.5543) | 0.005 |
| TNM stage | 2.462(1.457–4.158) | 0.001 | 2.506(1.480–4.246) | 0.001 |
Hazard ratios in univariate models
Hazard ratios in multivariable models
Abbreviations: HR, hazard ratio; 95 % CI, 95 % confidence interval.